NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.1 Alkylating drugs > Leukaemia (lymphocytic) - bendamustine - NICE TAG TA216

Leukaemia (lymphocytic) - bendamustine - NICE TAG TA216

1.1 Bendamustine is recommended as an option for the first-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate.

https://www.nice.org.uk/guidance/TA216

Site by Devopa
© Copyright 2019 NHS. All rights reserved.